HELIUS MEDICAL TECHNOLOGIES, INC. Contracts & Agreements
80 Contracts & Agreements
- Business Finance (37 contracts)
- Business Operations (6)
- Human Resources (27)
- Intellectual Property (1)
- Uncategorized (9)
- Sales Agreement, dated as of June 23, 2023, by and between the Company and Roth Capital Partners, LLC (Filed With SEC on June 23, 2023)
- Form of Warrant to purchase shares of common stock (Filed With SEC on August 9, 2022)
- Warrant Agency Agreement dated as of August 9, 2022 by and between Helius Medical Technologies, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on August 9, 2022)
- Form of Pre-Funded Warrant to purchase shares of common stock (Filed With SEC on August 9, 2022)
- Form of Securities Purchase Agreement by and between Helius Medical Technologies, Inc. and the purchasers named therein (Filed With SEC on August 9, 2022)
- Placement Agency Agreement dated as of August 5, 2022 by and between Helius Medical Technologies, Inc. and Roth Capital Partners, LLC (Filed With SEC on August 9, 2022)
- Form of Public Warrant (Filed With SEC on August 4, 2022)
- Form of Public Warrant (Filed With SEC on July 27, 2022)
- Form of Warrant Agency Agreement (Filed With SEC on July 27, 2022)
- Form of Pre-Funded Warrant (Filed With SEC on July 27, 2022)
- Form of Securities Purchase Agreement (Filed With SEC on July 27, 2022)
- Form of Placement Agency Agreement (Filed With SEC on July 27, 2022)
- Helius Medical Technologies, Inc. 2022 Equity Incentive Plan (Filed With SEC on February 18, 2022)
- Helius Medical Technologies, Inc. 2022 Equity Incentive Plan Form of Option Grant Agreement (Filed With SEC on February 18, 2022)
- Underwriting Agreement dated as of November 10, 2021, by and between Helius Medical Technologies, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on November 12, 2021)
- Employment Agreement by and between Helius Medical Technologies, Inc. and Antonella Favit-Van Pelt, effective as of July 7, 2021 (Filed With SEC on September 3, 2021)
- First Amendment to Securities Purchase Agreement, dated September 1, 2021 (Filed With SEC on September 3, 2021)
- Purchase Agreement, dated as of September 1, 2021, by and between Helius Medical Technologies, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 2, 2021)
- Registration Rights Agreement, dated as of September 1, 2021, by and between Helius Medical Technologies, Inc. and Lincoln Park Capital Fund, LLC (Filed With SEC on September 2, 2021)
- Separation and Release Agreement between Helius Medical Technologies, Inc. and Joyce LaViscount, dated August 17, 2021 (Filed With SEC on August 19, 2021)
- Employment Agreement by and between Helius Medical Technologies, Inc. and Dane C. Andreeff effective as of June 14, 2021 (Filed With SEC on June 15, 2021)
- Employment Agreement by and between Helius Medical Technologies, Inc. and Jeffrey S. Mathiesen effective as of June 14, 2021 (Filed With SEC on June 15, 2021)
- 2018 Omnibus Incentive Plan Form of Option Grant Agreement Initial Grants to Dane C. Andreeff and Jeffrey S. Mathiesen (Filed With SEC on June 15, 2021)
- Amendment to the Helius Medical Technologies, Inc. 2018 Omnibus Incentive Plan, effective as of May 25, 2021 (Filed With SEC on May 27, 2021)
- Non-employee Director Compensation Policy (Filed With SEC on May 17, 2021)
- 2018 Omnibus Incentive Plan Form of Stock Grant Notice and Award Agreement (Filed With SEC on April 7, 2021)
- Second Amendment to Employment Agreement between Helius Medical Technologies, Inc. and Joyce LaViscount dated April 1, 2021 (Filed With SEC on April 7, 2021)
- Description of Registrants Securities (Filed With SEC on March 10, 2021)
- Form of Indemnification Agreement (Filed With SEC on March 10, 2021)
- Underwriting Agreement dated as of January 28, 2021, by and between Helius Medical Technologies, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on February 1, 2021)
- Warrant Agency Agreement dated as of February 1, 2021, by and between Helius Medical Technologies, Inc. and American Stock Transfer & Trust Company, LLC (Filed With SEC on February 1, 2021)
- Underwriting Agreement (Filed With SEC on January 20, 2021)
- Form of Warrant (Filed With SEC on January 20, 2021)
- Form of Warrant Agency Agreement (Filed With SEC on January 20, 2021)
- Form of Underwriter Warrant (Filed With SEC on January 20, 2021)
- Non-Employee Director Compensation Policy, effective as of June 10, 2020 (Filed With SEC on November 12, 2020)
- Form of Warrant (Filed With SEC on October 26, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on October 26, 2020)
- 2018 Omnibus Incentive Plan Form of Option Grant Agreement 2020 Retention Grant (Filed With SEC on October 7, 2020)
- Interim President and CEO Employment Letter Agreement Between Helius Medical Technologies, Inc. and Dane C. Andreeff dated August 23, 2020 (Filed With SEC on August 25, 2020)
- Separation and Release Agreement between Helius Medical Technologies, Inc. and Philippe Deschamps dated August 23, 2020 (Filed With SEC on August 25, 2020)
- Promissory Note, between JPMorgan Chase Bank, N.A. and Helius Medical Technologies, Inc., dated April 6, 2020 (Filed With SEC on April 16, 2020)
- Form of Warrant (Filed With SEC on March 18, 2020)
- Form of Securities Purchase Agreement (Filed With SEC on March 18, 2020)
- Description of Registrants Securities (Filed With SEC on March 12, 2020)
- At The Market Offering Agreement by and between the Company and H.C. Wainwright & Co., LLC, dated January 27, 2020 (Filed With SEC on January 27, 2020)
- Underwriting Agreement by and among Helius Medical Technologies, Inc., H.C. Wainwright & Co., LLC and Haywood Securities Inc., dated November 22, 2019 (Filed With SEC on November 25, 2019)
- Form of Subscription Agreement (Filed With SEC on November 25, 2019)
- Separation Agreement between Helius Medical, Inc and Jennifer Laux, dated September 15, 2019 (Filed With SEC on November 12, 2019)
- Supplemental Agreement to Asset Purchase Agreement Dated October 9, 2015, between Helius Medical, Inc and A&B (HK) Company Limited, dated as of August 15, 2018 (Filed With SEC on March 14, 2019)
- Underwriting Agreement by and among Helius Medical Technologies, Inc., BTIG, LLC and Oppenheimer & Co. Inc., dated November 15, 2018 (Filed With SEC on November 16, 2018)
- 2018 Omnibus Incentive Plan, as amended (Filed With SEC on November 8, 2018)
- 2018 Omnibus Incentive Plan Form of Option Grant Agreement (Filed With SEC on November 8, 2018)
- 2018 Omnibus Incentive Plan Form of Restricted Stock Unit Grant Agreement (Filed With SEC on November 8, 2018)
- Employment agreement between Helius Medical Technologies, Inc. and Jennifer Laux, dated July 9, 2018, (incorporated by reference to Exhibit 99.1 to the Form 8-K filed July 12,... (Filed With SEC on August 9, 2018)
- 2018 Omnibus Incentive Plan (Filed With SEC on August 9, 2018)
- Underwriting Agreement, dated as of April 11, 2018, by and among the Company and the Underwriters (Filed With SEC on April 12, 2018)
- Form of Warrant Indenture (Filed With SEC on April 12, 2018)
- Commercial contract manufacturing agreement dated December 29, 2017 between NeuroHabilitation Corporation and Key Tronic Corporation (Filed With SEC on March 12, 2018)
- Amended and Restated June 2014 Equity Incentive Plan (Filed With SEC on November 9, 2017)
- Amendment of Solicitation/Modification of Contract of Sole-Source Cost Sharing Agreement with the U.S. Army Medical Research and Materiel Command (Filed With SEC on November 9, 2017)
- Amendment to Asset Purchase Agreement, dated October 30, 2017 (Filed With SEC on November 2, 2017)
- Modification No. 4 to the CRADA (Filed With SEC on September 12, 2017)
- UNDERWRITING AGREEMENT (Filed With SEC on February 9, 2017)
- Amendment to Performance Work Statement, dated November 7, 2016 (Filed With SEC on November 21, 2016)
- Performance Work Statement, dated July 1, 2015 (Filed With SEC on November 21, 2016)
- Master Cooperative Research and Development Agreement (CRADA), dated February 1, 2013 and related amendments (Filed With SEC on November 21, 2016)
- Amendment No. 1 to the Commercial Development-to-Supply Program between NeuroHabilitation Corporation and Ximedica, dated October 25, 2013, amended January 15, 2016 (Filed With SEC on May 4, 2016)
- Agency Agreement between the Company and Mackie Research Capital Corporation, dated as of March 23, 2016 (Filed With SEC on May 4, 2016)
- Sole-source cost sharing contract by and between NeuroHabilitation Corporation and the U.S. Army Medical Research and Materiel Command (USAMRMC) dated as of July 7, 2015 (Filed With SEC on May 4, 2016)
- Consulting Agreement between Helius Medical Technologies, Inc. and Montel Media, Inc., dated April 13, 2016 (Filed With SEC on May 4, 2016)
- Warrant Indenture by and between Helius Medical Technologies, Inc. and Computershare Trust Company of Canada, dated as of April 18, 2016 (Filed With SEC on April 20, 2016)
- Employment Agreement between Helius Medical Technologies, Inc. and Joyce LaViscount, dated October 19, 2015 (Filed With SEC on February 16, 2016)
- Employment Agreement between Helius Medical Technologies, Inc. and Brian Bapty, dated November 2, 2015 (Filed With SEC on February 16, 2016)
- Modification No. 3 to the CRADA, dated December 28, 2015 (Filed With SEC on December 31, 2015)
- Asset Purchase Agreement between the Company and A&B (HK) Company Limited, dated as ofOctober 9, 2015 (Filed With SEC on October 16, 2015)
- Convertible Promissory Note between the Company and A&B (HK) Company Limited, dated as of October 9, 2015 (Filed With SEC on October 16, 2015)
- Commercial Development-to-Supply Program between NeuroHabilitation Corporation and Ximedica, dated October 25, 2013 (Filed With SEC on September 23, 2014)
- License Agreement between Advanced NeuroRehabilitation, LLC and Yuri Danilov, Mitchell Tyler, Kurt Kaczmarek and John Klus, dated June 29, 2011 (Filed With SEC on September 23, 2014)
- Letter Agreement between the National Institutes of Health and Kurt Kaczmarek, Yuri Danilov and Mitchell Tyler, dated December 24, 2008 (Filed With SEC on September 23, 2014)